Entrectinib is an oral kinase inhibitor belonging to the TRK/ROS1 inhibitor class, indicated for the treatment of ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. This category… Read more








Entrectinib is an oral kinase inhibitor belonging to the TRK/ROS1 inhibitor class, indicated for the treatment of ROS1-positive non-small cell lung cancer and NTRK fusion-positive solid tumors. This category provides comprehensive analytical reference standards for Entrectinib, including its related impurities, metabolites, and stable isotope-labeled compounds. These high-quality materials are essential for pharmaceutical laboratories performing rigorous quality control and method validation. By utilizing these specific standards, researchers can conduct accurate impurity profiling and quantitation, ensuring compliance with regulatory requirements during drug development. Stable isotope-labeled versions are particularly valuable as internal standards in mass spectrometry-based bioanalytical assays, facilitating precise monitoring of drug concentrations in complex matrices. Whether developing new manufacturing processes or ensuring the consistency of the active pharmaceutical ingredient, these analytical tools support the complete life cycle of pharmaceutical testing.